Resmed Overview
Resmed (RMD) has a P/E ratio of 20.91, below the Healthcare sector average of 25.75.
Get informed when a big investor buys or sells
+ Follow20.91
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, RMD shows a P/E ratio of 20.91. That is below the Healthcare sector average of 25.75. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 25.75. Resmed is at 20.91, which is lower that average. That is roughly 18.8% below the sector mean. Use the comparison chart on this page to see how RMD stacks up against individual peers as well.
Investors watch RMD's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Resmed's latest reading is 20.91. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Resmed's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 20.91) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 25.75, while RMD is at 20.91. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
